Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by G1945Von May 02, 2024 10:28am
95 Views
Post# 36019400

RE:I feel good

RE:I feel good
MartyD wrote: I know when my team comes to me and asks me to acquire a second tool, they like what the new tool is helping them accomplish.  If there are competing brands of the tool on the market, I'm never surprised when they choose a different brand because that brand has re-engineered the tool to makes it even better.  Duke University buying a second unit tells me VPT is not only useful, it's the best option on the market. Sure. MAYO may feel a competing brand is better, but my guess is if the technicians at Duke feel VPT is the best and worth buying two, that many others will be taking notice and it won't be long before this gets going.  Especially when insurance companies start dictating the level of care. Insurance companies may start insisting on VPT before sending the patient for an MRI.  This should be hovering around .50 and head to a dollar so don't be surprised if it's spring loaded and it shoots past both those targets without giving us a chance to collect.  Just my opinion and I admit. I'm biased and waiting for 2025.


"MAYO may feel a competing brand is better"

Marty, was this a published comment by MAYO?



G1945V

<< Previous
Bullboard Posts
Next >>